Self-Administered Low-Dose Inhaled Methoxyflurane (Penthrox) during Administration of OnabotulinumtoxinA for Chronic Migraines: A Real World Case Series
The intramuscular administration of onabotulinumtoxinA (onabotA) has been well established as an effective preventative treatment for chronic migraines (CM). Though generally well tolerated, the procedure-related pain can be a large limitation of the treatment for patients with comorbidities such as...
Main Author: | Robert Hauptman |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-03-01
|
Series: | Canadian Journal of Pain |
Online Access: | http://dx.doi.org/10.1080/24740527.2019.1591891 |
Similar Items
-
Inhaled methoxyflurane (Penthrox) for analgesia in trauma: a systematic review protocol
by: Michael M. Eager, et al.
Published: (2021-02-01) -
Cognitive effects of onabotulinumtoxinA in chronic migraine
by: Susan Ho, et al.
Published: (2020-07-01) -
Prediction of patient's response to OnabotulinumtoxinA treatment for migraine
by: Franklin Parrales Bravo, et al.
Published: (2019-02-01) -
Adult Abdominal Migraine Improved by OnabotulinumtoxinA Injections
by: Neal Hermanowicz
Published: (2021-09-01) -
OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients
by: Ho-Tin Wong, et al.
Published: (2020-10-01)